Stocks and Investing
Stocks and Investing
Fri, April 14, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
George Sellers Reiterated (ANIK) at Hold and Held Target at $28 on, Apr 14th, 2023
George Sellers of Stephens & Co., Reiterated "Anika Therapeutics, Inc." (ANIK) at Hold and Held Target at $28 on, Apr 14th, 2023.
George has made no other calls on ANIK in the last 4 months.
There is 1 other peer that has a rating on ANIK. Out of the 1 peers that are also analyzing ANIK, all agrees with George's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Michael Petusky of "Barrington Research" Downgraded from Buy to Hold on, Tuesday, March 7th, 2023
Contributing Sources